search
Kodiak Sciences
Trends
- 1Kodiak Sciences Soars 150% After Drug Trial Success●Kodiak Sciences Up 150% At Opening Bell After Drugs Pass Key Trial
Kodiak Sciences shares jumped roughly 150% at the opening bell after the biotech's drug passed a key clinical trial. The strong trial results triggered a sharp rally in the stock, making the eye-disease drug developer one of the day's biggest gainers and drawing investor attention to its pipeline prospects.